Evidence map›Paper›PMID 40895382›Full record

ArticleGlobal health & medicine2025

Rising cognitive behavioral therapy claims among Japanese youth despite population decline: A retrospective study using the National Database of Health Insurance Claims (FY 20142022).

Masahide Usami, Masaya Ito, Yoshinori Sasaki, Masahiro Ishida, Saori Inoue, Katsunaka Mikami, Noa Tsujii, Hiroaki Kihara, Naoko Satake

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Global health & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masahide UsamiDepartment of Child and Adolescent Psychiatry, National Kohnodai Medical Center, Japan Institute for Health Security, Chiba, Japan.
Masaya ItoNational Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry, Kodaira, Japan.
Yoshinori SasakiDepartment of Child and Adolescent Psychiatry, National Kohnodai Medical Center, Japan Institute for Health Security, Chiba, Japan.
Masahiro IshidaDepartment of Psychiatry, Fukuoka University, Fukuoka, Japan.
Saori InoueDepartment of Child Psychiatry, Ehime University Graduate School of Medicine, Toon City, Japan.
Katsunaka MikamiDepartment of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.
Noa TsujiiDepartment of Child Mental Health and Development, Toyama University Hospital, Toyama, Japan.
Hiroaki KiharaDepartment of Neuropsychiatry, Kanazawa Medical Universiry, Ishikawa, Japan.
Naoko SatakeDepartment of Psychiatry, National Kohnodai Medical Center, Japan Institute for Health Security, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive behavioral therapy (CBT) is reimbursed under the national insurance system of Japan, although predominantly for adults. Recent mental health crises among children and adolescents have prompted policy reforms to expand access to CBT. This study aimed to assess trends in CBT insurance claims among Japanese youth (0-19 years) from fiscal year 2014-2022 using national claims data. Outpatient psychotherapy and CBT claims from the National Database of Health Insurance Claims (NDB) were analyzed and stratified by age group. Linear regression was applied to assess trends. The number of CBT claims for youth increased markedly from 691 (1.5%) in 2014 to 4,497 (12.8%) in 2022, with significant upward trends for ages 5-9, 10-14, and 15-19 (all

Indexed as

adolescentsCBTNDBpsychotherapyyouth

Identifiers

PMID40895382
PMCPMC12390773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.